In a significant stride towards fostering collaboration, innovation, and strategic decision-making in clinical research, Tranquil Clinical Research is thrilled to announce its participation in SCOPE Summit 2024. Now in its 15th year, SCOPE Summit

Tranquil Clinical Research is marking a momentous occasion this month – the celebration of its 10-year anniversary. A decade of excellence in clinical research, groundbreaking discoveries, and collaborative efforts that have significantly shaped the

Tranquil Clinical Research, represented by CEO and Founder, Karim Mohammed, and Vice President of Clinical Operations, Deborah Bates, played a pivotal role at the Outsourcing in Clinical Trials Event Series East 2023 (OCT East

In a dual celebration of achievement and commitment, Tranquil Clinical Research proudly announces its reception of two esteemed awards, the Seven Seas Award and the Patriotic Employer Award, both underscoring the company's dedication to

Expressing enthusiasm about Tranquil's attendance at the Bio Convention, the company's representatives look forward to immersing themselves in the wealth of knowledge and insights the event is expected to offer. As a trailblazer in

Nov-2021 Tranquil Clinical Research successfully completed a Phase II double blind, placebo controlled COVID trial as the full service CRO conducting all clinical trial operations including Protocol development, FDA submissions/approvals, pharmacovigilance, clinical project management,